Table 2.
Associations between cytokines and BD in the discovery and replication cohorts. Odds Ratios (ORs), 95% Confidence Interval (CI) and Variable Inclusion Probability (VIP) are shown. Variables with a VIP >0.75 are bolded and labeled with a dot.
Variables |
Discovery cohort |
Replication cohort |
||||||
---|---|---|---|---|---|---|---|---|
ORs | 95%CI | VIP | ORs | 95%CI | VIP | |||
Sex (Male) | 1.072 | [0.849,1.291] | 0.66 | 0.800 | [0.547,1.197] | 0.78 | ||
Sex (Female) | 0.933 | [0.775,1.177] | 0.66 | 1.249 | [0.836,1.829] | 0.78 | ||
Age | 1.022 | [1.005,1.036] | 1.00 | 0.995 | [0.967,1.018] | 0.621 | ||
BMI (Kg.m-2) | 1.027 | [1.001,1.067] | 0.88 | 1.049 | [0.993,1.154] | 0.9 | ||
IDS-C30 | 0.986 | [0.972,0.998] | 0.98 | |||||
HDRS-17 | 1.041 | [0.932,1.149] | 0.70 | |||||
Tobacco smoking (no) | 0.932 | [0.776,1.126] | 0.63 | 1.082 | [0.695,1.706] | 0.71 | ||
Tobacco smoking (yes) | 1.073 | [0.888,1.289] | 0.63 | 0.924 | [0.587,1.439] | 0.71 | ||
History of alcohol abuse (no) | 0.952 | [0.738,1.169] | 0.62 | |||||
History of alcohol abuse (yes) | 1.051 | [0.856,1.353] | 0.62 | |||||
History of substance abuse (no) | 0.940 | [0.748,1.233] | 0.66 | |||||
History of substance abuse (yes) | 1.063 | [0.813,1.338] | 0.66 | |||||
Antidepressants (no) | 1.706 | [1.4,2.113] | 1.00 | 1.634 | [1.046,3.074] | 0.93 | ||
Antidepressants (yes) | 0.587 | [0.473,0.715] | 1.00 | 0.612 | [0.326,0.957] | 0.93 | ||
Benzodiazepines (no) | 1.234 | [1.028,1.524] | 0.96 | 0.469 | [0.251,0.806] | 0.99 | ||
Benzodiazepines (yes) | 0.811 | [0.656,0.972] | 0.96 | 2.131 | [1.241,3.985] | 0.99 | ||
Antipsychotics (no) | 0.633 | [0.486,0.785] | 1.00 | 0.699 | [0.464,0.98] | 0.96 | ||
Antipsychotics (yes) | 1.580 | [1.273,2.054] | 1.00 | 1.430 | [1.02,2.155] | 0.96 | ||
Lithium (no) | 0.447 | [0.285,0.685] | 1.00 | 0.727 | [0.381,1.404] | 0.82 | ||
Lithium (yes) | 2.233 | [1.455,3.513] | 1.00 | 1.373 | [0.712,2.614] | 0.82 | ||
Anticonvulsants (no) | 0.488 | [0.368,0.641] | 1.00 | 0.335 | [0.167,0.626] | 1.00 | ||
Anticonvulsants (yes) | 2.046 | [1.553,2.717] | 1.00 | 2.979 | [1.592,5.98] | 1.00 | ||
Other psychotropic drugs (no) | 0.966 | [0.705,1.242] | 0.60 | 0.795 | [0.534,1.237] | 0.70 | ||
Other psychotropic drugs (yes) | 1.034 | [0.805,1.418] | 0.60 | 1.256 | [0.808,1.872] | 0.70 | ||
Antiinflammatory drugs (no) | 0.834 | [0.372,1.819] | 0.61 | 0.825 | [0.374,1.98] | 0.68 | ||
Antiinflammatory drugs (yes) | 1.197 | [0.551,2.689] | 0.61 | 1.212 | [0.505,2.669] | 0.68 | ||
CCL2 (pg/ml) | 1.001 | [0.999,1.003] | 0.64 | 0.999 | [0.997,1.001] | 0.65 | ||
CCL3 (pg/ml) | 1.001 | [0.992,1.004] | 0.58 | 1.000 | [0.976,1.023] | 0.78 | ● | |
CCL4 (pg/ml) | 0.999 | [0.996,1.004] | 0.56 | 0.998 | [0.994,1.003] | 0.66 | ||
CCL11 (pg/ml) | 1.000 | [0.998,1.002] | 0.47 | 0.999 | [0.997,1] | 0.77 | ● | |
CCL13 (pg/ml) | 1.000 | [0.997,1.002] | 0.53 | 0.999 | [0.992,1.004] | 0.66 | ||
CCL17 (pg/ml) | 1.000 | [1,1] | 0.64 | 0.999 | [0.998,1.001] | 0.63 | ||
CCL22 (pg/ml) | 1.000 | [1,1] | 0.70 | 1.000 | [1,1.001] | 0.71 | ||
CXCL10 (pg/ml) | 0.999 | [0.99,1] | 0.93 | ● | 1.000 | [0.997,1.002] | 0.65 | |
IL-6 (pg/ml) | 0.948 | [0.832,0.996] | 0.88 | ● | 1.002 | [0.767,1.184] | 0.52 | |
IL-7 (pg/ml) | 1.000 | [0.979,1.032] | 0.56 | 1.014 | [0.968,1.079] | 0.60 | ||
IL-8 (pg/ml) | 0.995 | [0.972,1.006] | 0.72 | 1.000 | [0.999,1.001] | 0.65 | ||
IL-10 (pg/ml) | 1.177 | [0.877,1.618] | 0.88 | ● | 2.067 | [0.703,7.366] | 0.83 | ● |
IL-12/IL-23 p40 (pg/ml) | 1.000 | [0.997,1.004] | 0.61 | 1.000 | [0.992,1.008] | 0.69 | ||
IL-15 (pg/ml) | 1.198 | [0.979,1.792] | 0.75 | ● | 1.800 | [1.008,4.641] | 0.81 | ● |
IL-16 (pg/ml) | 1.000 | [0.998,1] | 0.70 | 0.999 | [0.996,1.003] | 0.52 | ||
IL-27 (pg/ml) | 1.000 | [1,1.01] | 0.79 | ● | 1.000 | [1,1.001] | 0.75 | ● |
IFN- (pg/ml) | 0.996 | [0.977,1.015] | 0.67 | 0.977 | [0.918,1.09] | 0.74 | ||
TNF- (pg/ml) | 1.002 | [0.739,1.121] | 0.69 | 1.258 | [0.928,1.716] | 0.85 | ● |